Patent details

EP3731824 Title: PHARMACEUTICAL TABLET COMPOSITIONS OF DABIGATRAN

Basic Information

Publication number:
EP3731824
PCT Application Number:
TR2018050919
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP188990139
PCT Publication Number:
WO2019151966
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL TABLET COMPOSITIONS OF DABIGATRAN
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES DE DABIGATRAN SOUS FORME DE COMPRIMÉS
German Title of Invention:
MEHRSCHICHTIGE TABLETTENZUSAMMENSETZUNGEN VON DABIGATRAN
SPC Number:

Dates

Filing date:
27/12/2018
Grant date:
15/03/2023
EP Publication Date:
04/11/2020
PCT Publication Date:
08/08/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/03/2023
EP B1 Publication Date:
15/03/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/12/2023
Expiration date:
27/12/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/03/2023
 
 

Name:
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Address:
Istinye Mah. Balabandere Cad. No:14, 34460 Sariyer/Istanbul, Türkiye (TR)

Inventor

1

Name:
PALANTÖKEN, Arzu
Address:
Türkiye (TR)

2

Name:
TÜRKYILMAZ, Ali
Address:
Türkiye (TR)

3

Name:
YAVUZ, Büsra
Address:
Türkiye (TR)

4

Name:
GÜLKOK, Yildiz
Address:
Türkiye (TR)

Priority

Priority Number:
201722630
Priority Date:
28/12/2017
Priority Country:
Türkiye (TR)

Classification

IPC classification:
A61K 9/20; A61K 31/4439;

Publication

European Patent Bulletin

Issue number:
202311
Publication date:
15/03/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages